The Colorado Springs Chapter of Women on Wheels, the Mountain Shadow Riders, will host a motorcycle blood run Aug. 12 at the Memorial Health System administration center.
The run starts at 11 a.m. in the parking lot of Perkins Restaurant, 6005 Constitution Ave.
“As motorcyclists, we ride free with the wind in our hair, but that freedom comes at a price. We are more at risk of injuries when we are out on the road,” said a news release from the group. “If we make contact with a cage (motorized 4-wheel vehicle) or the asphalt, it’s pretty easy to assume that we will be hurt more seriously than the driver of the cage.”
The Blood Run is a hosted blood drive partnership with Memorial Health System’s Blood Mobile. Memorial Health System is the designated trauma hospital for Colorado Springs and has the busiest emergency department in Colorado.
Memorial Health System transfuses about 750 units, or pints, of blood every month. More than 75 percent of the blood transfused for patients at the hospital is collected from mobile blood drives held in the community.
Most of the blood collected from donors is used at Memorial Hospital. However, in times of crisis or if there are blood shortages in Colorado or nationwide, Memorial Health System will provide other centers with blood.
Nationally, only about 5 percent of those eligible to donate blood do so.
Women on Wheels was founded in California by an avid female motorcyclist in 1982. Its purpose is to unite all women motorcycle enthusiasts, whether they ride their own machines, are passengers or future motorcyclists.
WOW chapters are located throughout the United States, Canada and Europe. WOW has more than 3,500 members and continues to grow.
Mountain Shadow Riders is the local Colorado Springs chapter and received its charter in 1998. There are more than 50 full and support members. Each year Mountain Shadow Riders sponsors a Breast Cancer Awareness “Memory Ride.” All proceeds are donated to the Colorado Springs affiliate of the Susan G. Komen Breast Cancer Foundation.
To date, MSR has donated more than $11,000.
Women’s Associates P.C. has received re-accreditation in OB/GYN ultrasound from the American Institute of Ultrasound in Medicine.
The accreditation process involved review of the practice, including personnel, physical facilities, quality assurance methods and continuing education of the doctors and staff. The process ensures that the images and their interpretations meet or exceed nationally accepted standards.
Drs. Pamela Richards, Jill Murray, Deborah Lasley, Jennifer Even and Lisa Hovenga consider this achievement another step in their commitment to providing excellent obstetrical and gynecological care to their patients.
The first patient has been enrolled in an FDA-approved trial that will provide clinical data about the reduction of arterial blockage in above-the-knee arteries using Turbo-Booster, a product developed by Spectranetics.
The trial will involve 85 patients in at least 15 sites.
The patient is a 72-year-old female suffering from severe, lifestyle limiting claudication. The artery treated was six millimeters in diameter and was 85 percent blocked prior to the procedure. Following multiple passes with the Turbo-Booster device, the stenosis was reduced to 25 percent. The results of the procedure were sufficient for a stand-alone case result that did not require further adjunctive treatment with other devices.
“The … product is designed to facilitate laser ablation of larger diameter arteries above the knee, such as the superficial femoral artery,” said John G. Schulte, Spectranetics’ president and chief executive officer.
Spectranetics is a medical device company that develops, manufactures and markets single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system in conjunction with its proprietary excimer laser system. Excimer laser technology delivers relatively cool ultraviolet energy to ablate or remove arterial blockages including plaque, calcium and thrombus.
Baxa Corp., a Colorado manufacturer of medical devices for health-system pharmacies, was selected as one of “50 Companies to Watch” by Medical Device and Diagnostic Industry magazine in its review of the medical device industry.
Nominations were solicited from MD&DI readers, its editorial advisory board,
reader board and industry observers. The magazine chose companies with track
records or the potential for success, and technology breakthroughs or transformations
of standards of care that its editors felt were worth monitoring.
This is the first year that Baxa has received the designation.
The complete list is published in the June 2006 issue. Individual winner profiles can be viewed at http://www.devicelink.com/mddi/archive/06/06/002.html
Amy Gillentine covers health care for the Colorado Springs Business Journal.